Jeff Garro
Stock Analyst at Stephens & Co.
(1.21)
# 3,736
Out of 5,090 analysts
56
Total ratings
36.84%
Success rate
-10.69%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $23.84 | +34.23% | 6 | Dec 4, 2025 | |
| OPRX OptimizeRx | Maintains: Equal-Weight | $20 → $17 | $14.24 | +19.38% | 4 | Nov 17, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $3.94 | +128.43% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $20.29 | +57.71% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $19.64 | +1.83% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $23.02 | +21.63% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $242.00 | +15.70% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $2.60 | +92.31% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $9.22 | +84.38% | 5 | Feb 27, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $2.46 | +103.25% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $55 | $45.93 | +19.75% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $225.85 | +10.69% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $19.95 | -14.79% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $7.59 | +268.91% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $19.55 | +2.30% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $5.03 | -22.47% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $1.39 | +115.83% | 3 | May 6, 2022 |
Privia Health Group
Dec 4, 2025
Reiterates: Overweight
Price Target: $32
Current: $23.84
Upside: +34.23%
OptimizeRx
Nov 17, 2025
Maintains: Equal-Weight
Price Target: $20 → $17
Current: $14.24
Upside: +19.38%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $3.94
Upside: +128.43%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $20.29
Upside: +57.71%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $19.64
Upside: +1.83%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $23.02
Upside: +21.63%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $242.00
Upside: +15.70%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.60
Upside: +92.31%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $9.22
Upside: +84.38%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $2.46
Upside: +103.25%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $45.93
Upside: +19.75%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $225.85
Upside: +10.69%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $19.95
Upside: -14.79%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $7.59
Upside: +268.91%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $19.55
Upside: +2.30%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $5.03
Upside: -22.47%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $1.39
Upside: +115.83%